Neuberg Diagnostics launches Geniee: A personalized genomics platform

New Delhi: Neuberg Diagnostics has announced a development in personalized healthcare with the launch of Geniee – “Decode your DNA.” The new platform represents a significant advancement in the realm of genetic testing, poised to transform how individuals manage their health based on their unique genetic profiles.

The unveiling of Geniee was honored by Padmashri Dr. Kamal Haasan, who officially launched the mobile application. Geniee is designed to deliver tailored health insights by decoding users’ genetic information, allowing them to make informed decisions about their health and wellness. The platform offers detailed guidance on how genetic factors influence responses to medications, dietary preferences, exercise routines, and nutritional needs.

The centerpiece of Geniee’s launch is the Complete Wellness Genetics Test. This comprehensive analysis provides users with actionable insights into various aspects of their health, from identifying potential risks like obesity or nutritional deficiencies to recommending optimal dietary choices. The service aims to empower individuals by offering personalized health strategies that can significantly improve their well-being.

Dr. GSK Velu, Chairman & Managing Director of Neuberg Diagnostics, emphasized, “At Neuberg, we believe that personalized medicine is the future of healthcare. Geniee is not just about testing—it’s about giving individuals the power to take control of their health by offering them invaluable insights.”

Padmashri Dr. Kamal Haasan described Geniee as a transformative step in personalized medicine. “Genomics has the power to transform healthcare by offering tailored health insights based on an individual’s unique genetic makeup. Geniee empowers people to take control of their health, make informed decisions, and adopt preventive measures that could shape their future well-being. This is a major leap forward in our pursuit of personalized wellness, and I believe it will pave the way for a healthier and more informed society.”

Geniee’s platform leverages the principles of pharmacogenomics, which studies how genetic variations affect drug metabolism and responses. This approach aims to minimize adverse drug reactions, which account for 6.7% of hospitalizations and deaths. By tailoring drug prescriptions to individual genetic profiles, Geniee can reduce the risk of ineffective treatments and side effects by up to 30%.

Dr. Sandip Shah, Joint Managing Director of Neuberg Diagnostics, highlighted, “A Recent study on pharmacogenomics landscape in the Indian population revealed each Indian individual carries on an average eight variants directly impacting medication dose and type of Medicine.”

“Pharmacogenomics is at the heart of Geniee, and it is changing the landscape of medicine. It represents a paradigm shift in healthcare, where the one-size-fits-all approach is replaced with tailored treatments based on a person’s genetic makeup. This game-changing service aligns with our commitment to excellence in diagnostics and patient care,” added Dr. Shah.